© 1997 by European Society of Cardiology
Copyright © 1997, European Society of Cardiology
Gene transfer and cell transplant: an experimental approach to repair a broken heart
aCardiology Division, Soroka Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
bThe Institute of Genetic Medicine, Department of Medicine, Good Samaritan Hospital, University of Southern California, Los Angeles, CA, USA
cDepartment of Biochemistry and Molecular Biology, Good Samaritan Hospital, University of Southern California, Los Angeles, CA, USA
dThe Heart Institute, Good Samaritan Hospital, University of Southern California, Los Angeles, CA, USA
* Corresponding author. The Heart Institute, Good Samaritan Hospital, 1225 Wilshire Blvd., Los Angeles, CA 90017, USA. Tel.: +1 (213) 977 4050; fax: +1 (213) 977 4107.
Received 5 March 1997; accepted 27 May 1997
KEYWORDS Cardiomyocyte; Gene therapy; Myocardial infarction; Rat
| The first 150 words of the full text of this article appear below. |
| 1 Introduction |
|---|
Despite significant progress in prevention and therapy of ischemic heart disease, treating patients with heart failure after myocardial infarction remains a major therapeutic challenge. Adult cardiomyocytes cannot regenerate after injury. Therefore, cardiomyocyte loss due to myocardial infarction is irreversible. Currently, congestive heart failure is the only major cardiovascular disorder that is increasing in incidence and mortality [1]. Thus, there is still a need to develop alternative therapeutic strategies to prevent, arrest or reverse congestive heart failure after myocardial infarction.
Recent insights into the pathogenesis of myocardial disease and advances in molecular biology have opened up a new era of molecular and cellular therapies that target genes, molecules and peptides. Gene transfer as a therapeutic approach for the treatment of myocardial infarction and congestive heart failure has been suggested as a new treatment strategy for these serious disorders [2, 3]. The introduction, into injured myocardium, of recombinant transgenes that
| 2 Post-infarction left ventricular dysfunction |
|---|
| 3 Gene transfer into the ischemic or infarcted myocardium |
|---|
| 4 Molecular cardiomyoplasty: gene therapy with MyoD |
|---|
| 5 Cell transplant |
|---|
| 6 Other strategies |
|---|
| 7 Unresolved issues and challenges |
|---|
| 8 Summary and future research |
|---|
This article has been cited by other articles:
![]() |
M. Khan, V. K. Kutala, D. S. Vikram, S. Wisel, S. M. Chacko, M. L. Kuppusamy, I. K. Mohan, J. L. Zweier, P. Kwiatkowski, and P. Kuppusamy Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2129 - H2139. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Lee and R. R. Makkar Stem-Cell Transplantation in Myocardial Infarction: A Status Report Ann Intern Med, May 4, 2004; 140(9): 729 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-F. Xiao, J.-Y. Min, and J. P. Morgan Immunosuppression and xenotransplantation of cells for cardiac repair Ann. Thorac. Surg., February 1, 2004; 77(2): 737 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Blatt, D. Robinson, G. Cotter, S. Efrati, Y. Simantov, I. Bar, E. Kaluski, R. Krakover, S. Sidenko, Z. Evron, et al. Improved regional left ventricular function after successful satellite cell grafting in rabbits with myocardial infarction Eur J Heart Fail, December 1, 2003; 5(6): 751 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Etzion, I. M. Barbash, M. S. Feinberg, P. Zarin, L. Miller, E. Guetta, R. Holbova, R. A. Kloner, L. H. Kedes, and J. Leor Cellular Cardiomyoplasty of Cardiac Fibroblasts by Adenoviral Delivery of MyoD Ex Vivo: An Unlimited Source of Cells for Myocardial Repair Circulation, September 24, 2002; 106(12_suppl_1): I-125 - I-130. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, J.-Y. Min, J. S. Rana, Q. Ke, J. Cai, Y. Chen, J. P. Morgan, and Y.-F. Xiao VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells J Appl Physiol, September 1, 2002; 93(3): 1140 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Min, Y. Yang, K. L. Converso, L. Liu, Q. Huang, J. P. Morgan, and Y.-F. Xiao Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats J Appl Physiol, January 1, 2002; 92(1): 288 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jain, H. DerSimonian, D. A. Brenner, S. Ngoy, P. Teller, A. S. B. Edge, A. Zawadzka, K. Wetzel, D. B. Sawyer, W. S. Colucci, et al. Cell Therapy Attenuates Deleterious Ventricular Remodeling and Improves Cardiac Performance After Myocardial Infarction Circulation, April 10, 2001; 103(14): 1920 - 1927. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-K. Li, R. D. Weisel, D. A. G. Mickle, Z.-Q. Jia, E.-J. Kim, T. Sakai, S. Tomita, L. Schwartz, M. Iwanochko, M. Husain, et al. AUTOLOGOUS PORCINE HEART CELL TRANSPLANTATION IMPROVED HEART FUNCTION AFTER A MYOCARDIAL INFARCTION J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 62 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sinnaeve, O. Varenne, D. Collen, and S. Janssens Gene therapy in the cardiovascular system: an update Cardiovasc Res, December 1, 1999; 44(3): 498 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Allen Myocardial protection: is there a role for gene therapy? Ann. Thorac. Surg., November 1, 1999; 68(5): 1924 - 1928. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sakai, R.-K. Li, R. D. Weisel, D. A.G. Mickle, Z.-Q. Jia, S. Tomita, E.-J. Kim, and T. M. Yau FETAL CELL TRANSPLANTATION: A COMPARISON OF THREE CELL TYPES J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 715 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Rebolledo, P. Krogstad, F. Chen, K. M. Shannon, and T. S. Klitzner Infection of Human Fetal Cardiac Myocytes by a Human Immunodeficiency Virus-1–Derived Vector Circ. Res., October 5, 1998; 83(7): 738 - 742. [Abstract] [Full Text] [PDF] |
||||








